Cite
Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
MLA
Bökkerink, J. P., et al. “Sequence-, Time- and Dose-Dependent Synergism of Methotrexate and 6-Mercaptopurine in Malignant Human T-Lymphoblasts.” Biochemical Pharmacology, vol. 35, no. 20, Oct. 1986, pp. 3549–55. EBSCOhost, https://doi.org/10.1016/0006-2952(86)90625-8.
APA
Bökkerink, J. P., Bakker, M. A., Hulscher, T. W., De Abreu, R. R., Schretlen, E. D., van Laarhoven, J. P., & De Bruyn, C. H. (1986). Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Biochemical Pharmacology, 35(20), 3549–3555. https://doi.org/10.1016/0006-2952(86)90625-8
Chicago
Bökkerink, J P, M A Bakker, T W Hulscher, R R De Abreu, E D Schretlen, J P van Laarhoven, and C H De Bruyn. 1986. “Sequence-, Time- and Dose-Dependent Synergism of Methotrexate and 6-Mercaptopurine in Malignant Human T-Lymphoblasts.” Biochemical Pharmacology 35 (20): 3549–55. doi:10.1016/0006-2952(86)90625-8.